cruxpoint logo

Breakthroughs in life and living.

static-hero-back-1400
For Enterprise

FOR SELF-INSURED
ENTERPRISES AND
INSURANCE CARRIERS

Restoring health for the
high-cost, high-risk plan
members with chronic
non-communicable
disease.

Overview

Cruxpoint is a health innovation company providing breakthrough solutions to consumers and enterprises to stop and reverse chronic non-communicable diseases such as heart disease, diabetes, autoimmune diseases, and obesity. We deliver cost-effective methods for resolving chronic diseases, improving health outcomes, and reducing healthcare costs.

The Problem

The United States is spending too much on healthcare: $4.5 trillion, $13,500 per person, and ~18% of GDP (2022). Healthcare inflation relentlessly outpaces standard inflation, with costs landing on taxpayers, enterprises, and individuals. $4.5 Trillion graphic goes to the right

Key Issues:

  • Over 70% of costs treat non-communicable chronic diseases.
  • Bulk of spending goes to advanced and late-stage disease.
  • Chronic diseases are endemic with incidence rates rising every year.
  • Hitting younger ages, driving additional unsustainable costs. 70% of costs graphic goes to the right

CRUXPOINT’S UNIQUE CAPABILITIES

1. Revolutionary Health Restoration
  • Innovations in halting and reversing chronic diseases
  • Methods for restoring health and vitality, moving people out of “sick care,” “pharma care,” and “bodyshop” models where symptoms are managed for lifetimes.
2. Proven Cost Reduction
  • Significantly reduce healthcare costs by targeting the 15% of employees who drive over 80% of costs in self-insured companies
  • High per-client ROI in highest-cost, highest-risk employees where run-rate costs exceed $2,000 per month and long-term claims exceed $1 million
3. Complete Program Management
  • Enroll potential participants and build their desire and commitment
  • Maintain commitment throughout the program
  • Teach sustainable results for lasting health transformation

CRUXPOINT’S TARGET POPULATIONS

  • Focused exclusively on high-cost, high-risk population of plan members
  • Multi-point solution targeting multiple illnesses under a single vendor contract
  • Interventionists who interrupt progression of established high-cost, high-risk illnesses
  • Halt and reverse diseases, restore natural health, safely reduce medications, and prevent expensive hospitalizations and catastrophic events
  • Hard metrics for goals and success measurement, focusing on critical bio-markers and measurable cost reductions
  • Guaranteed significant ROI

MAXIMUM ROI THROUGH STRATEGIC TARGETING

For decades, companies have been promised ROI for wellness and prevention programs. These promises have not been kept. Cruxpoint demonstrates genuine, measurable ROI by tracking and changing actual and projected costs.

Real-World Example – Key Cost Drivers:

Plan with 4,000+ members spending over $7.5 million annually on pharmaceuticals:

  • 93 members cost $3.8 million in 1 year (2024)
  • Average per-person cost: $41,000
  • 2–5% of members caused over 50% of pharma costs
  • These members impose long-term costs ranging from
    $20K to over $50K annually
  • ~15% cause over 80% of costs on a long-term run rate

WHO WE ENROLL

We only enroll those representing the very best opportunity for restoring health, lowering costs, and providing substantial ROI.

HIGH-COST, HIGH-RISK CANDIDATES:
  • On expensive specialty drugs
  • History of ER, ICU, Urgent Care, or hospital visits
  • High cost run-rates from drugs, procedures, hospitalizations
  • T2D facing lifetime of weight-loss and diabetes drugs
  • Measurable hypertension and/or coronary artery disease
  • Autoimmune conditions requiring immune-suppressant drugs
  • Cancer diagnosis with relapse/new cancer risk
  • Significant musculoskeletal conditions imposing high costs
  • Obesity and co-morbidities
HIGH-RISK FUTURE COST CANDIDATES:
  • Heart health: Coronary Calcium Volume Score above 400, or high-risk patients on statins/
    LDL-lowering drugs (Rapatha, Praluent) plus anti-platelets
  • Autoimmune: Those at risk of requiring expensive biologic immune-suppressant drugs
  • Obesity: Clearly on path toward adverse health events and high costs
  • T2D: Data suggesting progression to expensive events, drugs, and procedures

OUR BUSINESS PURPOSE & VISION

  • BUSINESS PURPOSE: Halt and reverse chronic diseases, reduce enterprises’ healthcare costs, and restore health and vitality to individuals.
  • MISSION: Scale solutions to the chronic disease epidemic.

Our Services and Market

  • CORE SERVICE: 2-year engagement designed to halt and reverse individuals’ high-cost, high-risk chronic diseases.
  • PRIMARY MARKET: Self-insured enterprises and health insurance carriers.
  • GUARANTEE HIGH ROI: by halting and reversing expensive, dangerous chronic diseases.

YOUR STRATEGIC HEALTHCARE PARTNER

Cruxpoint doesn’t just provide a service—we partner with forward-thinking enterprises to fundamentally transform their healthcare landscape. Together, we can turn your biggest cost challenge into your greatest competitive advantage while giving your employees their health back.

More Resources on How We Support You

Shareable / emailable topic-specific support documents